"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, ...
Researchers find DMT – used in shamanic rituals – in tandem with psychotherapy has significant effect ...
FREMONT, CA, Oct. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire-- ABVC BioPharma, Inc. (ABVC) (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company ...
DENVER, COLORADO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines to treat ...
A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of ...
Johnson & Johnson’s decision to splash out $14.6 billion on its purchase of Intra-Cellular Therapies earlier this year was largely driven by the acquired company's rising antipsychotic star Caplyta ...
FILE - Food and Drug Administration (FDA) building is shown in Silver Spring, Md., Dec. 10, 2020. (AP Photo/Manuel Balce Ceneta, File) (Manuel Balce Ceneta, Copyright ...
Findings provide rationale for targeted strategy in psychiatry that may lead to new personalized treatments for major depressive disorder and other conditions ...
Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of interest in everyday activities, appetite changes, sleep disturbances and, in ...
Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet ...
Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar depression. Clinical trials showed significant symptom improvement and potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results